- Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome(2018)
Authors: Hannah Ceuleers, Nikita Hanning, Leen Heirbaut, Samuel Van Remoortel, Jurgen Joossens, Pieter Van Der Veken, Sven Francque, Michelle De bruyn, Joris De Man, Jean-Pierre Timmermans, et al.
Pages: 3516 - 3533
- Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome(2016)
Authors: Hannah Ceuleers, Hanne Van Spaendonk, Nikita Hanning, Leen Heirbaut, Anne-Marie Lambeir, Jurgen Joossens, Koen Augustyns, Joris De Man, Ingrid De Meester, Benedicte De Winter
Pages: 10275 - 10286
- Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9(2016)
Authors: Leen Heirbaut, Sebastiaan van Goethem, Koen Jansen, Hans De Winter, Nicole Lamoen, Jurgen Joossens, Jonathan Cheng, Xin Chen, Anne-Marie Lambeir, Ingrid De Meester, et al.
Pages: 433 - 438
- Heteroannelated pyrrolidines and prolines as inhibitors of dipeptidyl peptidases and related enzymes(2015)
Authors: Leen Heirbaut
Number of pages: 281
- Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)(2014)
Authors: Koen Jansen, Leen Heirbaut, Robert Verkerk, Jonathan D. Cheng, Jurgen Joossens, Paul Cos, Ingrid De Meester, Koen Augustyns, Pieter Van Der Veken
Pages: 3053 - 3074
- Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold(2014)
Authors: Koen Jansen, Hans De Winter, Leen Heirbaut, Jonathan D. Cheng, Jurgen Joossens, Ingrid De Meester, Koen Augustyns, Pieter Van Der Veken
Pages: 1700 - 1707
- Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold(2013)
Authors: Koen Jansen, Leen Heirbaut, Jonathan D. Cheng, Jurgen Joossens, Oksana Ryabtsova, Paul Cos, Ingrid De Meester, Koen Augustyns, Pieter Van Der Veken
Pages: 491 - 496